Swiss Re’s Abbott ABT Stock Holding History

Swiss Re’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.1K	Hold	391	–	–	0.25%	51
2025 Q4	$49K	Buy	+391	New	+$49.8K	﹤0.01%	43

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Swiss Re's ABT Position: Q1 2026 in Review

Swiss Re held its Abbott (ABT) position steady in Q1 2026 at 391 shares worth $40.1K. The position accounts for 0.25% of the portfolio, ranked #51.

Swiss Re first reported a position in ABT in Q4 2025 and has held it in 2 quarters since. The position peaked at $49K in Q4 2025. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Swiss Re held 391 shares of Abbott worth $40.1K as of Q1 2026.
Swiss Re left its Abbott share count unchanged in Q1 2026.
Abbott made up 0.25% of Swiss Re's portfolio in Q1 2026, its #51 holding.
Swiss Re first reported a position in Abbott in Q4 2025 and has held it in 2 quarters since.
Swiss Re's Abbott position peaked at $49K in Q4 2025.
3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.